Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged (TSE:NOVO)

TSX:NOVO

NOVO

Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged

RESEARCH TOOLSreports

Want to see TSE:NOVO full AI Analyst Report?

Compare Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged (NOVO) vs. Competitors

60 Followers

Comparison Results

NOVO

Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged

―

C$242.66B

―

-16.63%

―

Roche Holding Ltd CAD Hedged CIBC CDR

―

C$445.23B

―

14.48%

―

Novartis AG CAD Hedged CIBC CDR

―

C$379.62B

―

13.46%

―

Sanofi SA Unsponsored CDR Hedged Reg S

―

C$158.25B

―

-4.77%

―

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S

―

C$212.29B

6.44

7.09%

―

Merck & Co., Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S

―

C$400.10B

2.64

9.31%

―

xxxxxxxxxxxxx

NOVO vs MRK

xxxxxxxxxxxxx

Performance Comparison

TSE:NOVO

Novo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged

16.95

-2.88

-14.53%

TSE:ROG

Roche Holding Ltd CAD Hedged CIBC CDR

24.66

3.55

16.79%

TSE:NVS

Novartis AG CAD Hedged CIBC CDR

27.74

3.77

15.72%

TSE:SNY

Sanofi SA Unsponsored CDR Hedged Reg S

21.05

-1.05

-4.77%

TSE:PFE

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S

12.24

1.00

8.89%

TSE:MRK

Merck & Co., Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S

25.95

2.38

10.10%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >